We take a closer look at Gilead's pipeline strategy and dealmaking activity in 2026 as the company attempts to broaden its focus beyond HIV. The post Gilead’s pipeline strategy in 2026: A broadening focus beyond HIV appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.